Nova Patents
AT407122T

Azadecalin glucocorticoid receptor modulators

Abstract

The invention claims a kind of new type nitrogen heterocyclic alkyl naphthalene compound and and these compounds are useful as glucocorticoid receptor modulators method for.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

29 members in 18 offices

This recordMember, by publication datePriority claim8 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
53546004United States of AmericaP

Members29

Family members, oldest first
DocumentOfficeKind
AU2005206497A1AustraliaA1
CA2552419A1CanadaA1
WO2005070893A2World Intellectual Property Organization (WIPO)A2
NO20063456LNorwayL
IL176706A0IsraelA0
KR20070009561ARepublic of KoreaA
WO2005070893A3World Intellectual Property Organization (WIPO)A3
EP1761497A2European Patent Office (EPO)A2
HK1097409A1Hong Kong, ChinaA1
JP2007517894AJapanA
US2007203179A1United States of AmericaA1
ZA200605634BSouth AfricaB
CN101119970AChinaA
EP1761497B1European Patent Office (EPO)B1
AT407122TThis recordAustriaT
ATE407122T1AustriaT1
PT1761497EPortugalE
DE602005009530D1GermanyD1
DK1761497T3DenmarkT3
ES2313296T3SpainT3
US7678813B2United States of AmericaB2
US2010120759A1United States of AmericaA1
NZ548374ANew ZealandA
AU2005206497B2AustraliaB2
JP4851345B2JapanB2
KR101135885B1Republic of KoreaB1
IL176706AIsraelA
US8324203B2United States of AmericaB2
CA2552419CCanadaC